4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-20-005789
EVP, Chief Financial Officer acquired 80,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shukla Sath EVP, Chief Financial Officer | 2020-01-29 | Grant or award | +80,500 | 80,500 | D | ||
| Derivatives | |||||||
| Shukla Sath EVP, Chief Financial Officer | 2020-01-29 | Grant or award · Employee Stock Option (right to buy) | +123,900 | 123,900 | D | ||
Loading xslF345X03/doc4.xml…